These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 5436029)

  • 41. [Experimental psychoses and schizophrenia].
    Morselli GE
    Riv Neurobiol; 1964; 10(4):Suppl:1170-6. PubMed ID: 5827094
    [No Abstract]   [Full Text] [Related]  

  • 42. [Comparative study of the effects of lysergic acid diethylamide (LSD25) and of lysergic acid bromodiethylamide (BOL148) on short-term memory].
    Sterescu-Volanschi M
    Rev Roum Physiol; 1972; 9(4):363-9. PubMed ID: 4666652
    [No Abstract]   [Full Text] [Related]  

  • 43. [Congenital abnormalities possibly induced by LSD-25. Review of the literature apropos of a personal case].
    Jeanbart P; Bérard MJ
    Gynecol Obstet (Paris); 1971; 70(2):215-30. PubMed ID: 5563850
    [No Abstract]   [Full Text] [Related]  

  • 44. Lysergide and chromosome abnormalities.
    Nielsen J; Friedrich U; Jacobsen E; Tsuboi T
    Br Med J; 1968 Jun; 2(5608):801-3. PubMed ID: 4872155
    [No Abstract]   [Full Text] [Related]  

  • 45. [Psycho-dysleptics].
    Polvan O
    Turk Tip Cemiy Mecm; 1966 Nov; 32(11):661-70. PubMed ID: 5979072
    [No Abstract]   [Full Text] [Related]  

  • 46. [Genetic damage due to LSD? In vivo study of 11-LSD abusers].
    Obe G; Herha J
    Fortschr Med; 1973 Apr; 91(12):533-6. PubMed ID: 4702402
    [No Abstract]   [Full Text] [Related]  

  • 47. Lysergic acid diethylamide and chromosome breakage.
    Sturelid S; Kihlman BA
    Hereditas; 1969; 62(1):259-62. PubMed ID: 5399213
    [No Abstract]   [Full Text] [Related]  

  • 48. [Placental transport of the lysergic acid D-diethylamide (LSD-25)].
    Egozcue J
    Acta Obstet Ginecol Hisp Lusit; 1969 Feb; 17(2):135-46. PubMed ID: 5795736
    [No Abstract]   [Full Text] [Related]  

  • 49. Lysergic acid diethylamide intake in pregnancy: fetal damage in rats.
    Alexander GJ; Gold GM; Miles BE; Alexander RB
    J Pharmacol Exp Ther; 1970 May; 173(1):48-59. PubMed ID: 5445458
    [No Abstract]   [Full Text] [Related]  

  • 50. [Noxious effects of various drugs and medicaments on the genetic material. II. The problem of lysergic acid diethylamide (LSD)].
    Armendares S
    Gac Med Mex; 1971 Mar; 101(3):291-7. PubMed ID: 5576320
    [No Abstract]   [Full Text] [Related]  

  • 51. Psychedelic agents in creative problem-solving: a pilot study.
    Harman WW; McKim RH; Mogar RE; Fadiman J; Stolaroff MJ
    Psychol Rep; 1966 Aug; 19(1):211-27. PubMed ID: 5942087
    [No Abstract]   [Full Text] [Related]  

  • 52. [Experimental contribution to the problem of possible crossed tolerance between psychotic drugs of different structure].
    MISSERE G; TONINI G
    Boll Soc Ital Biol Sper; 1959 Sep; 35():1119-20. PubMed ID: 14422940
    [No Abstract]   [Full Text] [Related]  

  • 53. [Various psychodysleptic substances].
    Bernik V
    Rev Paul Med; 1972 Aug; 80(2):115-7. PubMed ID: 4671580
    [No Abstract]   [Full Text] [Related]  

  • 54. Studies on the concurrent behavioral and neurochemical effects of psychoactive drugs using the push-pull cannula.
    Tilson HA; Sparber SB
    J Pharmacol Exp Ther; 1972 Jun; 181(3):387-98. PubMed ID: 5033008
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of LSD-25 and mescaline on the electroplax of the electric eel.
    Webb GD; Farquharson DA
    Am J Physiol; 1971 Dec; 221(6):1802-8. PubMed ID: 4330905
    [No Abstract]   [Full Text] [Related]  

  • 56. Environmental influences upon drug-induced suppression of operant behavior.
    Sparber SB; Tilson HA
    J Pharmacol Exp Ther; 1971 Oct; 179(1):1-9. PubMed ID: 5096565
    [No Abstract]   [Full Text] [Related]  

  • 57. Lysergic acid diethylamide and chromosome damage--its controversy.
    Carter CH; Carpenter DG; Connolly JM
    J Fla Med Assoc; 1972 Feb; 59(2):29-31. PubMed ID: 5060438
    [No Abstract]   [Full Text] [Related]  

  • 58. Cumulative alterations in rat behavior during continuous administration of LSD or mescaline: absence of tolerance?
    Ellison G; Ring M; Ross D; Axelrood B
    Biol Psychiatry; 1980 Feb; 15(1):95-102. PubMed ID: 7357060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Sensory deprivation and psychodysleptic activity].
    Roche M
    C R Seances Soc Biol Fil; 1970; 164(8):1756-62. PubMed ID: 4253202
    [No Abstract]   [Full Text] [Related]  

  • 60. The mutagenic effect of lysergic acid diethylamide. III. Evaluation of the genetic risk of LSD in man.
    Srám RJ; Goetz P
    Mutat Res; 1974 Dec; 26(6):523-8. PubMed ID: 4431425
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.